A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study ...

New magnetic nanoparticles in the shape of a cube sandwiched between two pyramids represent a breakthrough for treating ...

In a study on ovarian cancer cells, researchers from Karolinska Institutet demonstrate how the tumor environment influences ...

A research team led by Sheri Holmen, Ph.D., investigator at Huntsman Cancer Institute and professor in the Department of ...

Genmab categorically refutes these allegations and will vigorously defend the company against AbbVie’s claims. Genmab notes that this is yet another lawsuit among multiple recent lawsuits filed by ...

Women of childbearing age who had both ovaries removed, in a procedure called bilateral oophorectomy, were more likely to develop heart failure later in life, according to a study being presented at ...

Toon Van Gorp, MD, PhD, a MIRASOL trial investigator, emphasizes that the final analysis reinforces the efficacy of mirvetuximab soravtansine-gynx (Elahere; AbbVie) in patients with folate receptor ...

AbbVie’s Elahere (mirvetuximab soravtansine-gynx) has demonstrated consistent survival benefits in a subset of ovarian cancer ...

Toon Van Gorp, MD, PhD, discussed findings from the MIRASOL trial and the potential of mirvetuximab to redefine treatment ...

AbbVie recently announced the final analysis from the Phase III MIRASOL trial, showcasing the effectiveness of Elahere for treating platinum-resistant ovarian cancer. Elahere demonstrated a ...

AbbVie's Elahere maintains strong efficacy in the Phase 3 MIRASOL trial for ovarian cancer, with durable survival benefits ...

US-based pharmaceutical company AbbVie has reported the final analysis from the Phase III MIRASOL trial, which assessed its ...